You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 202294


✉ Email this page to a colleague

« Back to Dashboard


NDA 202294 describes DEXLANSOPRAZOLE, which is a drug marketed by Mylan, Par Pharm Inc, and Twi Pharms, and is included in three NDAs. It is available from seven suppliers. Additional details are available on the DEXLANSOPRAZOLE profile page.

The generic ingredient in DEXLANSOPRAZOLE is dexlansoprazole. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
Summary for 202294
Tradename:DEXLANSOPRAZOLE
Applicant:Par Pharm Inc
Ingredient:dexlansoprazole
Patents:0
Pharmacology for NDA: 202294
Mechanism of ActionProton Pump Inhibitors
Medical Subject Heading (MeSH) Categories for 202294
Suppliers and Packaging for NDA: 202294
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXLANSOPRAZOLE dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 202294 ANDA Par Pharmaceutical, Inc. 49884-147 49884-147-11 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49884-147-11)
DEXLANSOPRAZOLE dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 202294 ANDA Par Pharmaceutical, Inc. 49884-148 49884-148-09 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49884-148-09)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength60MG
Approval Date:Apr 19, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength30MG
Approval Date:Jun 16, 2022TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.